Fed. Circ. Nixes Shire Win In Generic Lialda Case
The Federal Circuit on Friday reversed a ruling that Actavis Inc.'s generic version of inflammatory bowel disease treatment Lialda infringed a Shire Development LLC patent, finding the lower court had made...To view the full article, register now.
Already a subscriber? Click here to view full article